FIELD: medicine, pharmaceutical industry.
SUBSTANCE: invention relates to composition for peroral administration based on paracetamole remantadine, ascorbic acid rutine, loratadine and calcium gluconate. Claimed agent contains two different capsules or tablets which after administration provide therapeutic effect. Agent has febrifuge, antiviral, anti-inflammation, anti-allergic, etc. action, stimulates secretion of interferon-alpha and interferon-beta, and makes it possible to reduce time of influenza and viral infection treatment by 2-3 days.
EFFECT: stable pharmaceutical composition of prolonged storage time useful in large scale production.
10 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-INFLUENZA COMPLEX PREPARATION | 2001 |
|
RU2234922C2 |
COMBINED PREPARATION TO REMOVE SYMPTOMS OF CATARRHAL DISEASES AND GRIPPE (VARIANTS) | 2003 |
|
RU2237475C1 |
AGENT FOR INFLUENZA TREATMENT | 2003 |
|
RU2229877C1 |
COMBINED MEDICINAL PREPARATION IN FORM OF EFFERVESCENT TABLETS AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2686694C2 |
METHOD OF TREATING AVIAN INFLUENZA | 2012 |
|
RU2502512C2 |
COMBINED PREPARATION FOR INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS | 2012 |
|
RU2498797C2 |
DIINDOLYLMETHANE DRUG PREPARATION AND USING IT FOR TREATING INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2537025C1 |
COMBINED PREPARATION FOR REMOVING SYMPTOMS OF CATARRHAL DISEASES AND GRIPPE (VARIANTS) | 2003 |
|
RU2237470C1 |
COMBINED PREPARATION FOR ELIMINATION OF SYMPTOMS AND TREATING ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA | 2013 |
|
RU2611383C2 |
DRUG FOR PREVENTION AND TREATMENT OF INFLUENZA TYPES A AND B | 2008 |
|
RU2380100C1 |
Authors
Dates
2006-11-10—Published
2004-11-22—Filed